Could a vitamin cocktail fix energy problems in autism?

NCT ID NCT03835117

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests whether a wide-spectrum nutritional supplement can improve mitochondrial function in children with autism spectrum disorder (ASD). Mitochondria are the energy factories in cells, and some children with ASD have abnormal mitochondrial activity. The trial enrolls children aged 4 to 14 with confirmed ASD and mitochondrial dysfunction, giving them either the supplement or a placebo for 26 weeks. Researchers measure changes in mitochondrial activity and autism symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wide-spectrum nutritional supplement (NeuroNeeds: Spectrum Needs and Q Needs)
What this could lead to
If the supplement normalizes mitochondrial activity, it could point toward a dietary approach to support metabolism in children with autism.
What could go wrong
This is a small, early-phase trial with only 16 children, so results may not apply broadly. The supplement is a mix of many ingredients, making it hard to know which, if any, are responsible for effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Southwestern Research & Resource Center

    Phoenix, Arizona, 85016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.